Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01 - Salvatore Siena; Kanwal Raghav; Toshiki Masuishi; Kensei Yamaguchi; Tomohiro Nishina; Elena Elez; Javier Rodriguez; Ian Chau; Maria Di Bartolomeo; Hisato Kawakami; Fumitaka Suto; Makito Koga; et al. (Nature Communications)